Opioids – Moving Forward With Pain Therapeutics

Pain Therapeutics 2014
Pain Therapeutics 2014
Spread the Word
Listed Under

* Pain
* Opioid
* Chronic Pain
* Antagonist
* Cannabiniods

* Biotech
* Health

* London City - London, Greater - England

LONDON - May 13, 2014 - PRLog -- Senior scientists, academics and KOLSs will gather next week in London to assess alternative approached to animal models, opioid abuse, plus much more at SMi’s 14th annual Pain Therapeutics conference.

The industry established event will provide a truly global audience with attendees from Australia, Belgium, France, Germany, Netherlands, Spain, Sweden, Switzerland, United Arab Emirates, United Kingdom and USA, with leading experts from:

Abbott Laboratories, Anderson Cancer Center, Barnet & Chase Farm Hospitals NHS Trust, Cambridgeshire County Council, Centre for Human Drug Research, Cistim, Cubist Pharmaceuticals Inc, Eli Lilly, GW Pharmaceuticals, Glenmark Pharmaceutials, Helsinn Healthcare, Imperial College London, Johnson And Johnson, Merck Sharp & Dohme Limited (MSD), Mundipharma Research, Nektar Therapeutics, Neuroscience Technologies, OGBConsulting, Orion Pharma, PHC Qatar, Polycraft, PRA International, Spinifex Pharmaceuticals, Stockholm Brain Institute, Technology & Medicine, The Medicines Company, The University Of Sheffield, Theravance, UCB, University of Oxford, VETOQUINOL plus many more…

Abbvie’s insights into pain research will be one of the conference highlights this year at the 2 day event. When asked what attendees will take away from his talk, Philip Kym, Director of Chemistry, Centralised Lead Optimisation, said:

“We have discovered novel clinical ready candidates with comprehensive preclinical packages in 4 new mechanisms (TRPV1, Cav2.2, Nav1.7, TrkA). These assets are available for interested parties to take forward into clinical investigation.”

“Sharing information on challenges that face all of us in the pain therapeutic area will hopefully create a path forward for navigating the hurdles (ie FDA) that prevent us from bringing new drugs forward in this area.”

For those interested in attending, bookings can be made online at http://www.smi-online.co.uk/goto/2014pain-therapeutics26.asp

Holiday Inn Kensington Forum , London UK


About SMi Group

Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries.
We pride ourselves on having access to the worlds most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. We hold events in over 30 major cities throughout the world including London, Paris and Singapore and to date have welcomed over 200,000 participants from 80 countries.

More information can be found at www.smi-online.co.uk

SMi Group
Source:SMi Group
Email:***@smi-online.co.uk Email Verified
Tags:Pain, Opioid, Chronic Pain, Antagonist, Cannabiniods
Industry:Biotech, Health
Location:London City - London, Greater - England
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Page Updated Last on: May 13, 2014
SMi Group Ltd. News
Daily News
Weekly News

Like PRLog?
Click to Share